Researchers to work collaboratively and with a sense of immediacy to ascertain the best use of currently available tools and develop and advocate for funding for a comprehensive research agenda that takes into account the specific needs of pediatric TB patients, patients co-infected with HIV and other common co-morbidities such as Hepatitis C. Less toxic, more potent drugs to shorten the length of